| ABOUT LETI || PRODUCTS | |||||||
|
ABOUT LETI Laboratorios LETI, S.L. is an independent, family-owned, biopharmaceutical company dedicated to medicinal research. The company is based in Barcelona and its industrial plant and allergy research laboratory are located in Tres Cantos (Madrid). It has subsidiaries in Germany and Portugal and operates with exclusive distributors in |
|||||||
![]() |
|||||||
different European countries, South America and Africa. LETI closed the Business Year ending May 31st, 2005 with a turnover of more than 48 million euros, an increase of 17% compared to the previous year and a staff of 255 employees with an average age of 39, of whom 41% are graduates and doctors and 64%, women. Laboratorios LETI aspires to be regarded as an excellent company in which to work in the pharmaceutical sector and in the geographical areas in which it operates, as well as to have competitive staff who have earned great professional respect and can relate to the company values, strategies and objectives. Our directors and management staff are directly responsible for managing the people under their charge in their respective areas of activity, as well as for making known and applying the company’s strategy, objectives and policies. In the financial area, special attention is paid to generating free cash flows, with the support of the Department of Finance and Administration, and to the application of planning and control strategies that are in keeping with its business strategy and inspired in the integral management philosophy. The logistics and information systems and technologies division both report to Financial and Administrative Management. Laboratorios LETI is a founder-member of Asebio (Spanish Association of Biocompanies) and the EAMG (European Allergens Manufacturers Group), in addition to being a member of Farmaindustria, FENIN (Spanish Federation of Health Technology Companies) and the BPI (Bundesverband der Pharmazeutischen Industrie). In addition, it collaborates with a great many charity organisations and funds in areas related to health and education. |
|||||||
|
|
|||||||
|
|||||||